Active Pharmaceutical Ingredients Market by Manufacturing Type and Geography - Forecast and Analysis 2020-2024

Global Active Pharmaceutical Ingredients Market

About this market

Technavio’s active pharmaceutical ingredients market analysis considers sales from captive API and contract API. Our study also finds the sales of active pharmaceutical ingredients in Asia, Europe, North America, and ROW. In 2019, the contract API segment had a significant market share, and this trend is expected to continue over the forecast period. Factors such as the growing demand for low-cost drugs will play a significant role in the contract API segment to maintain its market position. Also, our global active pharmaceutical ingredients market report looks at factors such as evolving API manufacturing scenarios in developing countries, increasing the number of type II drug master (DMFs), and growing need to focus on core competencies. However, growing concerns regarding outsourced APIs and capacity utilization constraints may hamper the growth of the active pharmaceutical ingredients industry over the forecast period.

Global Active Pharmaceutical Ingredients Market

Overview

Increasing number of type II drug master files (DMFs)

The market has witnessed a steady rise in the number of DMF filings over the past two decades. This is due to the increasing investments to enhance manufacturing facilities by Asian companies to meet international quality standards. In addition, market players in India are increasingly focusing on achieving compliance with standards laid by various regulatory agencies such as the US FDA, TGA, MHRA, Brazilian Health Regulatory Agency, and SAHPRA. The increasing DMF approvals by regulatory agencies are providing significant growth opportunities for API manufacturers. Such factors will lead to the expansion of the global active pharmaceutical ingredients market at a CAGR of over 6% during the forecast period.

Paradigm shift in API manufacturing

Traditionally, most of the pharmaceutical companies have been relying on their in-house capabilities for the discovery, development, and manufacturing of APIs. However, the captive API manufacturing has seen an overhaul in the last few decades as many pharmaceutical companies are focusing on outsourcing a large share of their research and manufacturing processes to CMOs or other drug manufacturing organizations. The decision to outsource an API depends on several factors, such as industry trends, the cost of acquiring new in-house technologies, and the availability of internal capacity. Outsourcing of API enables innovators as well as generic drug manufacturers to meet aggressive development timelines while capitalizing significant efficiencies in the supply chain. This development is expected to have a positive impact on the overall market growth.

For the detailed list of factors that will drive the global active pharmaceutical ingredients market during the forecast period 2020-2024, click here.

Competitive Landscape

With the presence of several major players, the global active pharmaceutical ingredients market is fragmented. Technavio’s robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading active pharmaceutical ingredients manufacturers, that include Amneal Pharmaceuticals Inc., Cadila Healthcare Ltd., Jazz Pharmaceuticals Plc, Lupin Ltd., Mylan NV, Novartis AG, Pfizer Inc., Sun Pharmaceutical Industries Ltd., Teva Pharmaceutical Industries Ltd., and Thermo Fisher Scientific Inc.

Also, the active pharmaceutical ingredients market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage on all forthcoming growth opportunities.


  • Executive summary
  • Scope of the report
    • Preface
    • Currency conversion rates for US$
  • Market landscape
    • Market ecosystem
      • Table Global pharmaceuticals market
      • Table Segments of global pharmaceuticals market
    • Market characteristics
      • Table Market characteristics
    • Market segmentation analysis
      • Table Market segments
    • Value chain analysis
  • Market sizing
    • Market definition
      • Table Vendors: Key offerings
      • Table Market definition - Inclusions and exclusions checklist
    • Market sizing 2019
      • Table Market size 2019
    • Market size and forecast 2019-2024
      • Table Global market: Size and forecast 2019-2024 ($ billions)
      • Table Global market: Year-over-year growth 2020-2024 (%)
    • Market outlook
  • Five forces analysis
    • Table Five forces analysis 2019
    • Table Five forces analysis 2024
    • Bargaining power of buyers
      • Table Bargaining power of buyers
    • Bargaining power of suppliers
      • Table Bargaining power of suppliers
    • Threat of new entrants
      • Table Threat of new entrants
    • Threat of substitutes
      • Table Threat of substitutes
    • Threat of rivalry
      • Table Threat of rivalry
    • Market condition
      • Table Market condition - Five forces 2019
  • Customer landscape
    • Table Customer landscape
  • Market segmentation by manufacturing type
    • Table Manufacturing type - Market share 2019-2024 (%)
    • Comparison by manufacturing type
      • Table Comparison by manufacturing type
    • Captive API - Market size and forecast 2019-2024
      • Table Captive API - Market size and forecast 2019-2024 ($ billions)
      • Table Captive API - Year-over-year growth 2020-2024 (%)
    • Contract API - Market size and forecast 2019-2024
      • Table Contract API - Market size and forecast 2019-2024 ($ billions)
      • Table Contract API - Year-over-year growth 2020-2024 (%)
    • Market opportunity by manufacturing type
      • Table Market opportunity by manufacturing type
  • Geographic landscape
    • Geographic segmentation
      • Table Market share by geography 2019-2024 (%)
    • Geographic comparison
      • Table Geographic comparison
    • Asia - Market size and forecast 2019-2024
      • Table Asia - Market size and forecast 2019-2024 ($ billions)
      • Table Asia - Year-over-year growth 2020-2024 (%)
      • Table Top 3 countries in Asia
    • North America - Market size and forecast 2019-2024
      • Table North America - Market size and forecast 2019-2024 ($ billions)
      • Table North America - Year-over-year growth 2020-2024 (%)
      • Table Top 3 countries in North America
    • Europe - Market size and forecast 2019-2024
      • Table Europe - Market size and forecast 2019-2024 ($ billions)
      • Table Europe - Year-over-year growth 2020-2024 (%)
      • Table Top 3 countries in Europe
    • ROW - Market size and forecast 2019-2024
      • Table ROW - Market size and forecast 2019-2024 ($ billions)
      • Table ROW - Year-over-year growth 2020-2024 (%)
      • Table Top 3 countries in ROW
    • Key leading countries
      • Table Key leading countries
    • Market opportunity
      • Table Market opportunity
  • Decision Framework
  • Drivers and challenges
    • Market drivers
      • Table Cumulative number of DMFs filled 2001-2018
    • Market challenges
      • Table Total WLs issued 2010-2014
      • Table Impact of drivers and challenges
  • Market trends
    • Increasing geriatric population
    • Paradigm shift in API manufacturing
    • Increasing patent expiries
  • Vendor landscape
    • Overview
      • Table Vendor landscape
    • Landscape disruption
      • Table Landscape disruption
    • Competitive scenario
  • Vendor analysis
    • Vendors covered
      • Table Vendors covered
    • Vendor classification
      • Table Vendor classification
    • Market positioning of vendors
      • Table Market positioning of vendors
    • Amneal Pharmaceuticals Inc.
      • Table Amneal Pharmaceuticals Inc. - Vendor overview
      • Table Amneal Pharmaceuticals Inc. - Business segments
      • Table Amneal Pharmaceuticals Inc. - Organizational developments
      • Table Amneal Pharmaceuticals Inc. - Segment focus
      • Table Amneal Pharmaceuticals Inc. - Key offerings
      • Table Amneal Pharmaceuticals Inc. - Key customers
    • Cadila Healthcare Ltd.
      • Table Cadila Healthcare Ltd. - Vendor overview
      • Table Cadila Healthcare Ltd. - Business segments
      • Table Cadila Healthcare Ltd. - Organizational developments
      • Table Cadila Healthcare Ltd. - Geographic focus
      • Table Cadila Healthcare Ltd. - Key offerings
      • Table Cadila Healthcare Ltd. - Key customers
    • Jazz Pharmaceuticals Plc
      • Table Jazz Pharmaceuticals Plc - Vendor overview
      • Table Jazz Pharmaceuticals Plc - Business segments
      • Table Jazz Pharmaceuticals Plc - Organizational developments
      • Table Jazz Pharmaceuticals Plc - Geographic focus
      • Table Jazz Pharmaceuticals Plc - Key offerings
      • Table Jazz Pharmaceuticals Plc - Key customers
    • Lupin Ltd.
      • Table Lupin Ltd. - Vendor overview
      • Table Lupin Ltd. - Business segments
      • Table Lupin Ltd. - Organizational developments
      • Table Lupin Ltd. - Geographic focus
      • Table Lupin Ltd. - Key offerings
      • Table Lupin Ltd. - Key customers
    • Mylan NV
      • Table Mylan NV - Vendor overview
      • Table Mylan NV - Product segments
      • Table Mylan NV - Organizational developments
      • Table Mylan NV - Geographic focus
      • Table Mylan NV - Segment focus
      • Table Mylan NV - Key offerings
      • Table Mylan NV - Key customers
    • Novartis AG
      • Table Novartis AG - Vendor overview
      • Table Novartis AG - Business segments
      • Table Novartis AG - Organizational developments
      • Table Novartis AG - Geographic focus
      • Table Novartis AG - Segment focus
      • Table Novartis AG - Key offerings
      • Table Novartis AG - Key customers
    • Pfizer Inc.
      • Table Pfizer Inc. - Vendor overview
      • Table Pfizer Inc. - Business segments
      • Table Pfizer Inc. - Organizational developments
      • Table Pfizer Inc. - Geographic focus
      • Table Pfizer Inc. - Segment focus
      • Table Pfizer Inc. - Key offerings
      • Table Pfizer Inc. - Key customers
    • Sun Pharmaceutical Industries Ltd.
      • Table Sun Pharmaceutical Industries Ltd. - Vendor overview
      • Table Sun Pharmaceutical Industries Ltd. - Business segments
      • Table Sun Pharmaceutical Industries Ltd. - Organizational developments
      • Table Sun Pharmaceutical Industries Ltd. - Geographic focus
      • Table Sun Pharmaceutical Industries Ltd. - Key offerings
      • Table Sun Pharmaceutical Industries Ltd. - Key customers
    • Teva Pharmaceutical Industries Ltd.
      • Table Teva Pharmaceutical Industries Ltd. - Vendor overview
      • Table Teva Pharmaceutical Industries Ltd. - Business segments
      • Table Teva Pharmaceutical Industries Ltd. - Organizational developments
      • Table Teva Pharmaceutical Industries Ltd. - Segment focus
      • Table Teva Pharmaceutical Industries Ltd. - Key offerings
      • Table Teva Pharmaceutical Industries Ltd. - Key customers
    • Thermo Fisher Scientific Inc.
      • Table Thermo Fisher Scientific Inc. - Vendor overview
      • Table Thermo Fisher Scientific Inc. - Business segments
      • Table Thermo Fisher Scientific Inc. - Organizational developments
      • Table Thermo Fisher Scientific Inc. - Geographic focus
      • Table Thermo Fisher Scientific Inc. - Segment focus
      • Table Thermo Fisher Scientific Inc. - Key offerings
      • Table Thermo Fisher Scientific Inc. - Key customers
  • Appendix
    • Research methodology
      • Table Validation techniques employed for market sizing
    • List of abbreviations
    • Definition of market positioning of vendors
      • Table Definition of market positioning of vendors
  • Explore Technavio

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook